Literature DB >> 29181160

Secondary central nervous system lymphoma surrounding a region injured by subarachnoid hemorrhage and subsequent aneurysmal clipping.

Yoriko Murata1, Yasuhiro Hata2, Yoshihiro Noda2, Satoshi Matsusaka2, Naoki Fukui3, Tomohito Kadota3, Jun Iwata4, Takuya Machida5, Takuji Yamagami1.   

Abstract

The present case study describes a rare case of secondary central nervous system (CNS) lymphoma that infiltrated the dura and leptomeninges around the area injured by subarachnoid hemorrhage and subsequent aneurysmal clipping. Invasion of the CNS was observed by computed tomography as slurred fissures of the right parietal lobe adjacent to the surgery area. Subdural and subarachnoid enhancement overlapping the area injured by past surgical procedures was observed by contrast-enhanced magnetic resonance imaging. Surgical resection revealed B-cell lymphoma infiltrating the dura and leptomeninges surrounding the post-hemorrhagic area. The patient was subsequently diagnosed with systemic lymphoma and bone marrow invasion, and multiple lymph node swelling. To the best of our knowledge, this is the first report of malignant lymphoma involving the CNS overlapping a previously injured area.

Entities:  

Keywords:  central nervous system invasion; disrupted blood brain barrier; history of subarachnoid hemorrhage; malignant lymphoma

Year:  2017        PMID: 29181160      PMCID: PMC5700395          DOI: 10.3892/br.2017.981

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  10 in total

Review 1.  The dural tail sign--beyond meningioma.

Authors:  A Guermazi; F Lafitte; Y Miaux; C Adem; J-F Bonneville; J Chiras
Journal:  Clin Radiol       Date:  2005-02       Impact factor: 2.350

Review 2.  Hyperintensity in the subarachnoid space on FLAIR MRI.

Authors:  Stephen L Stuckey; Tony D Goh; Theresa Heffernan; David Rowan
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

Review 3.  CNS prophylaxis in lymphoma: who to target and what therapy to use.

Authors:  Quentin A Hill; Roger G Owen
Journal:  Blood Rev       Date:  2006-08-01       Impact factor: 8.250

Review 4.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

5.  Marginal zone B-cell lymphoma involving a longstanding fibrous meningioma: an initial manifestation of systemic disease.

Authors:  Sarah E Martin; Hasan S Khalidi; Eyas M Hattab
Journal:  Hum Pathol       Date:  2013-07-11       Impact factor: 3.466

6.  The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features.

Authors:  B A Johnson; E K Fram; P C Johnson; R Jacobowitz
Journal:  AJNR Am J Neuroradiol       Date:  1997-03       Impact factor: 3.825

Review 7.  Primary central nervous system lymphoma: radiologic-pathologic correlation.

Authors:  K K Koeller; J G Smirniotopoulos; R V Jones
Journal:  Radiographics       Date:  1997 Nov-Dec       Impact factor: 5.333

8.  Spread of malignant lymphoid cells into rat central nervous system with intact and disrupted blood-brain barrier.

Authors:  R Aho; S Vaittinen; K Jahnukainen; H Kalimo
Journal:  Neuropathol Appl Neurobiol       Date:  1994-12       Impact factor: 8.090

9.  CNS involvement in the non-Hodgkin's lymphomas.

Authors:  L J Levitt; D M Dawson; D S Rosenthal; W C Moloney
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

10.  Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.

Authors:  Jennie W Taylor; Eoin P Flanagan; Brian P O'Neill; Tali Siegal; Antonio Omuro; Lisa Deangelis; Joachim Baehring; Ryo Nishikawa; Fernando Pinto; Marc Chamberlain; Khe Hoang-Xuan; Alberto Gonzalez-Aguilar; Tracy Batchelor; Jean-Yves Blay; Agnieszka Korfel; Rebecca A Betensky; Maria-Beatriz S Lopes; David Schiff
Journal:  Neurology       Date:  2013-10-09       Impact factor: 9.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.